Adam Goulburn

Adam Goulburn has extensive work experience in the fields of venture capital and biotechnology. Adam is currently a Co-Founder at Dimension, a position they have held since March 2022. Prior to that, they worked at Lux Capital, where they held various roles including Venture Partner, Partner, Principal, Senior Associate, and Associate from March 2012 to August 2022. Adam also served as the Founding CEO at VNV Bio (now Aera Therapeutics) from October 2018 to January 2021, and at Kallyope from December 2014 to December 2015. Adam began their career as a Post-Doctoral Associate at Weill Cornell Medical College, where they worked from August 2010 to November 2011.

Adam Goulburn pursued their education by completing a Bachelor of Commerce / Bachelor of Science degree at UNSW from 2001 to 2005. This allowed him to gain knowledge in the fields of International Business, Accounting, and Biotechnology. Later, from 2006 to 2010, they attended Monash University where they earned their PhD in Stem Cell Research.